Could ICX-TRC be used to treat the hair loss found in alopecia areata and totalis?
We do not know if ICX-TRC could be used to treat these conditions. These conditions are thought to be caused by an autoimmune mechanism. Since ICX-TRC is autologous (meaning it uses the patient’s own cells) it may be that the underlying autoimmunity might attack and destroy ICX-TRC cells just as it attacked and destroyed intact hair follicle cells to cause the initial hair loss.